Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Multiple Sclerosis

  Free Subscription


06.07.2026

1 AJNR Am J Neuroradiol
1 Ann N Y Acad Sci
1 BMC Neurol
2 Brain
4 J Neurol
1 J Neurol Neurosurg Psychiatry
1 J Neurol Sci
9 Mult Scler
1 Muscle Nerve
2 N Engl J Med
1 Neurol Clin Pract


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. KIM J, Seo D, Jeong E, Kim SY, et al
    Assessment of Cortical Myelination in Patients with MS via T1-Weighted/FLAIR Ratio: A Longitudinal Follow-up Study.
    AJNR Am J Neuroradiol. 2026;47:1985-1993.
    PubMed         Abstract available


    Ann N Y Acad Sci

  2. CARVER JJ, Denbrock RR, Lau KM, Zeczycki TN, et al
    Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.
    Ann N Y Acad Sci. 2026;1561:e70329.
    PubMed         Abstract available


    BMC Neurol

  3. GNANAPAVAN S, Arun T, Gallagher P, Rushworth M, et al
    Evaluating the potential of sNfL as a biomarker in MS management in the UK: insights from SUNLIT survey.
    BMC Neurol. 2025;26:50.
    PubMed         Abstract available


    Brain

  4. HAY CM, Mahjoub A, Vidarsson L, Soltanieh S, et al
    Retinal hyper-reflective foci link retinal and cortical pathology in paediatric multiple sclerosis.
    Brain. 2026 Jul 1:awag235. doi: 10.1093.
    PubMed         Abstract available

  5. DUGAST E, Shah S, Vogel I, Loret A, et al
    Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.
    Brain. 2026 Jun 30:awag227. doi: 10.1093.
    PubMed         Abstract available


    J Neurol

  6. KOKS F, Reubens F, van der Zee H, Briede JJ, et al
    The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review.
    J Neurol. 2026;273:441.
    PubMed         Abstract available

  7. ARATAKE Y, Yoshinaga K, Ashida S, Fujii C, et al
    Beyond dissemination criteria: lesion-based longitudinal MRI of atypical demyelinating lesions at the boundary of multiple sclerosis.
    J Neurol. 2026;273:438.
    PubMed         Abstract available

  8. BOVE R, Langdon D, Maciejowski M, Jasinska E, et al
    Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study.
    J Neurol. 2026;273:434.
    PubMed         Abstract available

  9. CALISTRI V, Pezzella FR, Prosperini L
    Triple-crush mechanism in multiple sclerosis-associated trigeminal neuralgia.
    J Neurol. 2026;273:431.
    PubMed        


    J Neurol Neurosurg Psychiatry

  10. MAUNULA A, Laakso SM, Viitala M, Sumelahti ML, et al
    Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study.
    J Neurol Neurosurg Psychiatry. 2026 Jul 2:jnnp-2025-338301.
    PubMed         Abstract available


    J Neurol Sci

  11. GUO M, Liu H, Han J
    Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis.
    J Neurol Sci. 2026;489:126078.
    PubMed        


    Mult Scler

  12. YOO PY, Zarandi A, Stephens S, To T, et al
    Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.
    Mult Scler. 2026 Jun 29:13524585261453239. doi: 10.1177/13524585261453239.
    PubMed         Abstract available

  13. MACMILLAN EL, Russell-Schulz B, Alejo G, Harp C, et al
    Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.
    Mult Scler. 2026 Jun 30:13524585261456964. doi: 10.1177/13524585261456964.
    PubMed         Abstract available

  14. SUTHIPHOSUWAN S, Lim TR, Raufdeen F, Punpichet M, et al
    Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.
    Mult Scler. 2026 Jul 1:13524585261453816. doi: 10.1177/13524585261453816.
    PubMed         Abstract available

  15. BRIGGS FB, Litwiler J, Montini F, Fereidan Esfahani M, et al
    Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.
    Mult Scler. 2026 Jul 1:13524585261454207. doi: 10.1177/13524585261454207.
    PubMed         Abstract available

  16. GUILFOYLE D, Ward K, Klistorner S, Lizak N, et al
    Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.
    Mult Scler. 2026 Jul 1:13524585261459228. doi: 10.1177/13524585261459228.
    PubMed         Abstract available

  17. HEDSTROM AK, Stridh P, Hillert J, Olsson T, et al
    Interaction between smoking and HLA-A*02:01 in multiple sclerosis progression.
    Mult Scler. 2026 Jul 3:13524585261453243. doi: 10.1177/13524585261453243.
    PubMed         Abstract available

  18. BERGMANN C, Jackson D, Nicholson R, Bleyer L, et al
    Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysis.
    Mult Scler. 2026 Jul 3:13524585261459835. doi: 10.1177/13524585261459835.
    PubMed         Abstract available

  19. CHU NY, Roberts JI, Hunt DJ, Kuipers D, et al
    Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.
    Mult Scler. 2026 Jul 3:13524585261453817. doi: 10.1177/13524585261453817.
    PubMed         Abstract available

  20. MULLAN G, Ford HL, Blackall P, Bongol D, et al
    UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.
    Mult Scler. 2026 Jul 3:13524585261454551. doi: 10.1177/13524585261454551.
    PubMed         Abstract available


    Muscle Nerve

  21. DUBUISSON N, Kassab A, Van den Bergh PYK, Vrancken AFJE, et al
    Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis.
    Muscle Nerve. 2026 Jul 2. doi: 10.1002/mus.70282.
    PubMed         Abstract available


    N Engl J Med

  22. TORKILDSEN O, Brustad HK, Hogestol EA, Alstadhaug KB, et al
    Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.
    N Engl J Med. 2026;395:44-53.
    PubMed         Abstract available

  23. HAUSER SL
    Advances in Multiple Sclerosis.
    N Engl J Med. 2026;395:54-68.
    PubMed         Abstract available


    Neurol Clin Pract

  24. SOLOMON AJ, Zakaria M, Saylor DR, Viswanathan S, et al
    Global Access to Diagnostic Paraclinical Testing Incorporated in the 2024 Revised McDonald Criteria: Disparities and Opportunity.
    Neurol Clin Pract. 2026;16:e200633.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum